BPL Ltd manufactures single-sided and double-sided printed circuit boards for automotive, medical, and industrial sectors, while also earning royalty income by licensing its brand name to Reliance Retail for consumer electronics.
The company lacks a durable moat as evidenced by low average ROCE and net margins. While the BPL brand has legacy value, it is currently monetized through an asset-light licensing model rather than manufacturing dominance, and the core PCB business operates in a highly competitive, cost-sensitive commodity market.
Capital allocation is poor, characterized by a failure to redeem preference shares since 2019 due to insufficient profits and continued investment in a non-operational power subsidiary. Reinvestments in PCB capacity have yet to translate into robust or stable returns on capital.
The company's collapse was driven by the eventual crystallization of massive contingent liabilities and the forced liquidation of assets to address the decade-long failure to redeem preference shares. As the legacy brand value evaporated under an asset-light model that lacked reinvestment, the core PCB business succumbed to commodity price volatility and high customer concentration. The persistent drain from the non-operational power subsidiary finally exhausted the remaining liquidity, leading to a total breakdown in creditor confidence and a permanent impairment of equity value.
RichFakir rates BPL Ltd's business quality as poor — 12/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, BPL Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on BPL Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of BPL Ltd's fair value is about ₹13 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →